Therabest and Glycotope to assess breast cancer combination treatment
Therabest USA. Inc, Therabest Korea and Glycotope GmbH have signed an agreement to assess the…
Keep yourself up to date with the latest cell therapy news, including stem cell therapy, CAR-T cell therapy, and more. This section covers the latest updates on regulations, deals, and technology advancements of cell therapy companies.
Therabest USA. Inc, Therabest Korea and Glycotope GmbH have signed an agreement to assess the…
MicrofluidX (MFX), a U.K. based provider of next-generation bioreactors for cell research and manufacturing, has…
Neogene Therapeutics, Inc., a global clinical-stage biotechnology company pioneering the discovery, development and manufacturing of…
BioPharma Dynamics have expanded their portfolio for the cell and gene therapy market to offer…
Genome writing company Replay has received a $1.56 million grant from the Bill & Melinda…
The Cell and Gene Therapy Catapult (CGT Catapult) has published its ninth annual U.K. cell…
Gene editing has come far in the past decade. However, the field is still finding…
Companies in the cell and gene therapy space are struggling to raise investments amid adverse…
An agreement has been made to utilize the advantage of stem cells from human exfoliated…
Xcell Biosciences Inc. (Xcellbio), an instrumentation company focused on cell and gene therapy applications, and…
The companies Acelyrin, InnovaFeed and Arsenal Biosciences bagged the biggest biotech investments in September 2022,…
AmplifyBio has acquired select assets from PACT Pharma, Inc., a privately held biopharmaceutical company developing…